Join
Live feed
·
PRReleasevia Quantisnow
Astria Therapeutics Inc. logo

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE

ByQuantisnow·Wall Street's wire, on your screen.
ATXS· Astria Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXS (Astria Therapeutics Inc.) and more on Quantisnow.